Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02697071 · ClinicalTrials.gov registry record · NA
Ketamine for Acute Migraine in the Emergency Department
A NA study of Headache, sponsored by Carilion Clinic.
- Completed
- Registry status
- NA
- Development phase
- 34
- Enrollment target
- 1
- Study location
NCT02697071: Completed NA study of Headache, sponsored by Carilion Clinic.
NCT02697071 is a NA study of Headache that has completed, run by Carilion Clinic. The registered enrollment target is 34 participants, below the 155-participant average among 35 other Headache trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02697071, a NA study of Headache, has completed, sponsored by Carilion Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 34 participants
- Enrollment target
- 1
- Study location
Study Summary
This research study will be a prospective, randomized, double-blind, placebo-controlled trial. Because ketamine has yet to be directly studied as treatment for acute migraine headache in the emergency department, the research team is initially interested if ketamine can reduce pain scores in headache patients and reduce the incidence of recurrence while exhibiting an adequate safety profile. By using a placebo-controlled study design, the research team can adequately investigate the effectiveness of the medication in a subgroup previously not well studied.
Primary Outcome
NRS (National rating scale) pain score change from baseline following ketamine dose. Minimum score is 0, maximum score is 10, and higher scores mean worse pain.
Conditions Studied
Interventions
- DRUG Ketamine
- DRUG Normal Saline
Study Locations (1)
Virginia
- Carilion Roanoke Memorial Emergency Department - Roanoke
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2016-02 |
| Est. Completion | 2017-03 |
| Phase | NA |
What the finished NCT02697071 record still lists
NCT02697071 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 34 participants, a relatively small participant target, below the 155-participant average among 35 other Headache trials with a reported enrollment target (78% lower).
The record links to 1 condition, with Headache appearing as the primary indexed condition, and to 2 interventions - of which Ketamine is the first listed.
NCT02697071 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT02697071 about?
NCT02697071 is a clinical study titled "Ketamine for Acute Migraine in the Emergency Department". This research study will be a prospective, randomized, double-blind, placebo-controlled trial. Because ketamine has yet to be directly studied as treatment for acute migraine headache in the emergency department, the research team is initially interested if ketamine can reduce pain scores in headach...
What is the current status of trial NCT02697071?
This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2016-02. Estimated completion is 2017-03.
What conditions does trial NCT02697071 study?
This clinical trial studies the following conditions: Headache.
What interventions are being tested in trial NCT02697071?
The interventions under investigation include: Ketamine (DRUG), Normal Saline (DRUG).
Who is sponsoring clinical trial NCT02697071?
This trial is sponsored by Carilion Clinic, which has 45 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02697071 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Headache
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02697071's enrollment target sits among peer trials
34 26th of 35 higher than 9 of 35 other Headache trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Headache trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Concussion Recovery and Support Program
RECRUITING · NA
-
Responding With Evidence and Access for Childhood Headaches
RECRUITING · NA
-
Determining the Utility of a Behavioral Intervention in Chronic Migraine
RECRUITING · NA
-
Combined Transcranial Magnetic Stimulation and Therapy for MTBI Related Headaches
RECRUITING · NA
-
Mind Body Balance for Pediatric Migraine
RECRUITING · NA
-
Placebo Impacts Sleep and Pain Modulation in Chronic Pain
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02897063 · 34 participants · Phase 1
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
- NCT03906617 · 34 participants · Phase 4
Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine
- NCT03992378 · 34 participants · NA
Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis
- NCT04047849 · 34 participants · Phase 4
Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia